Find Articles



Return to:Diabetes Articles
Or:Recent Diabetes Articles

Transition Therapeutics Receives Remaining Upfront Payment from Elan ...


http://news.moneycentral.msn.com/provider/providerarticle...

MSN MoneyCentral - Transition's lead products include ELND-005/AZD-103 for the treatment of Alzheimer's disease and regenerative therapies E1-I.N.T.TM and GLP1-I.N.T.TM for the treatment of diabetes. Transition has an emerging pipeline of preclinical drug candidates ...



Article Finder:

October 26, 2007 04:40:00 AM
Article Directory